While no significant correlation in survival time was observed between LUSC and ACADL (P > 0.05), higher expression of ACADL showed a significant improvement in the prognosis of NSCLC (P < 0.001, Fig. 1b). The gene discussed is ACADL; the disease is non-small cell lung carcinoma.